Skip to main content
. Author manuscript; available in PMC: 2016 May 27.
Published in final edited form as: Oncology (Williston Park). 2014 Nov;28(11):974–980.

Figure 4. Overall Survival as a Function of the Presence or Absence of Visceral Metastases in Men With mCRPC Treated With Ipilimumab.

Figure 4

Kaplan-Meier estimates of overall survival. Data are from the CA184-043 study. Ipi = ipilimumab; OS = overall survival; Pbo = placebo.[46]